Clinical trials
Recruiting Neoplasms trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 11 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 37 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Amgen | 2 |
| AstraZeneca | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| BeOne Medicines | 1 |
| Bristol-Myers Squibb | 1 |
| CatalYm GmbH | 1 |
| Celgene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 37 |
| Neoplasms by Site | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Endometrial Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Recurrence | 4 |
| Hematologic Neoplasms | 3 |
| Immune System Diseases | 3 |
| Lung Diseases | 3 |
| Lung Neoplasms | 3 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.